Pharvaris President Exercises Options for 45,308 Shares

After the option exercise, the president directly held 110,261 Pharvaris common shares.

Rhea-AI Filing Summary

Pharvaris N.V. President Lu Peng exercised options to acquire 45,308 common shares on September 22, 2026, at an exercise price of $2.5900 per share. After the transaction, he directly held 110,261 common shares. The options vested 25% on February 3, 2021, with the remaining shares vesting in 1/48 monthly installments thereafter.

Insider Trade Summary

45,308 shares exercised/converted

Exercise 2 txns

Insider Lu Peng

Role President

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1	45,308	$0.00	$0.00
Exercise	Common Stock	45,308	$2.59	$117K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 110,261 shares (Direct)

Footnotes (1)

1. F1. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Key Figures

Common shares acquired: 45,308 shares Exercise price: $2.5900 per share Common shares held directly afterward: 110,261 shares +3 more

6 metrics

Common shares acquired 45,308 shares Option exercise on September 22, 2026

Exercise price $2.5900 per share Options exercised on September 22, 2026

Common shares held directly afterward 110,261 shares After the September 22, 2026 transaction

Option vested 25% Vested on February 3, 2021

Remaining vesting schedule 1/48 monthly installments Remaining option shares

Option expiration date February 3, 2030 Reported stock option

Key Terms

Stock Option (Right to Buy), vesting, exercise price

3 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

vesting financial

"remaining shares vesting in 1/48 monthly installments thereafter"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"exercise price of $2.5900 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PHVS shares did President Lu Peng acquire through the option exercise?

President Lu Peng acquired 45,308 common shares through the option exercise on September 22, 2026, at an exercise price of $2.5900 per share. His direct common-share holdings after the transaction were 110,261 shares.

What were the vesting terms for Lu Peng's PHVS options?

25% of the option vested on February 3, 2021, and the remaining shares vested in 1/48 monthly installments thereafter.

Was Lu Peng's PHVS option exercise reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:03 PM Accepted by SEC EDGAR 09/24/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Peng

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2026		M		45,308	A	$2.59	110,261	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.59	09/22/2026		M			45,308	(1)	02/03/2030	Common Stock	45,308	$0	0	D

Explanation of Responses:

1. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

	/s/ Marnus Nel, Attorney-in-Fact for Peng Lu	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)